Martin J. Edelman

14.3k citations
302 papers · 8.7k indexed · 2 hit papers · h-index 52
Topics
Lung Cancer Treatments and Mutations (141 papers)Lung Cancer Research Studies (81 papers)Lung Cancer Diagnosis and Treatment (72 papers)
Partner nations
United StatesCanadaSpain

In The Last Decade

Martin J. Edelman

295 papers receiving 8.5k citations

Hit Papers

A War on Two Fronts: Cancer Care in the Time of COVID-1920182026202020232020201850100150200250

Peers

Martin J. Edelman
Comparison fields: 5 of 152
  • Oncology 4.6k
  • Pulmonary and Respiratory Medicine 4.3k
  • Molecular Biology 2.0k
  • Surgery 1.0k
  • Cancer Research 946
Replace David E. Gerber with:
David E. Gerber United States
David S. Ettinger United States
Nasser H. Hanna United States
Alicia Samuels United States
Frank V. Fossella United States
Joachim G.J.V. Aerts Netherlands
Zhengjia Chen United States
Taylor Murray United States
Ateeq Ur Rehman Ghafoor Pakistan
Fausto Petrelli Italy
Martin J. Edelman relative to David E. Gerber United States David E. Gerber's profile →
Citations per field
00.5×1.5×
David E. Gerber · 1×
Citations per year

Countries citing papers authored by Martin J. Edelman

Since Specialization
Citations

This map shows the geographic impact of Martin J. Edelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin J. Edelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin J. Edelman more than expected).

Fields of papers citing papers by Martin J. Edelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin J. Edelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin J. Edelman. The network helps show where Martin J. Edelman may publish in the future.

Co-authorship network of co-authors of Martin J. Edelman

This figure shows the co-authorship network connecting the top 25 collaborators of Martin J. Edelman. A scholar is included among the top collaborators of Martin J. Edelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin J. Edelman. Martin J. Edelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 1
5 10
6 13
7 80
8 232
9
Results from the phase iii randomized trial of onartuzumab plus erlotinib versus erlotinib in previously treated stage iiib or iv non–small-cell lung cancer: METLung
1
10 10
11 85
12 46
13 48
14 54
15 36
16 12
17 38
18 8
19 2
20 27

About Martin J. Edelman

Martin J. Edelman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 302 papers that have together received 8.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (141 papers), Lung Cancer Research Studies (81 papers) and Lung Cancer Diagnosis and Treatment (72 papers). The work is most often cited by research in Oncology (4.6k citations), Pulmonary and Respiratory Medicine (4.3k citations) and Cancer Research (946 citations). Martin J. Edelman has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include David R. Gandara, Amy J. Davidoff, Brian Seal, Mohan Suntharalingam, Everett E. Vokes, Mark J. Krasna, Karen Kelly, Leno Thomas, L. Austin Doyle and Mark A. Socinski. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026